EWM
ABEO icon

Endurance Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Endurance Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10
Closed – – 613
2022
Q2 		$0 Hold
10
– – ﹤0.01% 623
2022
Q1 		$0 Hold
10
– – ﹤0.01% 639
2021
Q4 		$0 Hold
10
– – ﹤0.01% 625
2021
Q3 		$0 Hold
10
– – ﹤0.01% 632
2021
Q2 		$0 Hold
10
– – ﹤0.01% 626
2021
Q1 		$0 Hold
10
– – ﹤0.01% 642
2020
Q4 		$0 Hold
10
– – ﹤0.01% 619
2020
Q3 		$0 Hold
10
– – ﹤0.01% 617
2020
Q2 		$1K Hold
10
– – ﹤0.01% 573
2020
Q1 		$1K Hold
10
– – ﹤0.01% 527
2019
Q4 		$1K Hold
10
– – ﹤0.01% 499
2019
Q3 		$1K Buy
+10
New +$749 ﹤0.01% 501

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Endurance Wealth Management's ABEO Position: Q3 2022 in Review

Endurance Wealth Management sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 10 shares.

Endurance Wealth Management first reported a position in ABEO in Q3 2019 and held it in 12 quarters. The position peaked at $1K in Q2 2020. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • Endurance Wealth Management reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Endurance Wealth Management sold 10 Abeona Therapeutics shares in Q3 2022.
  • Endurance Wealth Management first reported a position in Abeona Therapeutics in Q3 2019 and held it in 12 quarters.
  • Endurance Wealth Management's Abeona Therapeutics position peaked at $1K in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on Endurance Wealth Management's 13F filing for Q3 2022, filed 21 Oct 2022.